Kou, X., Ding, H., Li, L., & Chao, H. Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9. Wiley.
Chicago Style (17th ed.) CitationKou, Xinxin, Hui Ding, Lei Li, and Hongtu Chao. Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9. Wiley.
MLA (9th ed.) CitationKou, Xinxin, et al. Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9. Wiley.
Warning: These citations may not always be 100% accurate.